Some people who have
hemophilia A develop antibodies to the injected
clotting factor. The body thinks that
the replacement clotting factors don't belong in the body, so it creates
the antibodies, also called inhibitors, to get rid of them.
Inhibitors may make it harder to treat bleeding episodes because the
body's natural defense system (
immune system) interferes with the
function of replacement clotting factors.
people produce few inhibitors; others produce many.
How can I be treated?
If you have inhibitors, hemophilia treatment may require
specially engineered replacement clotting factors. Other treatment for clotting
factor inhibitors includes therapy to suppress the immune system
If you have a larger amount of inhibitors, you might be treated with:
Factor bypassing agents. These clotting factors are used
to skip the part of the clotting process that requires either clotting factor
VIII or IX. This treatment is unpredictable, and it is hard to determine the
correct dose. This treatment also slightly increases
your risk of having a heart attack or developing blood clots.
regimen that allows the body to get used to the clotting factors so that they
won't produce as many or any inhibitors. This is done by giving large amounts
of clotting factors daily over an extended period of time.
During the first part of the treatment, you will get a factor bypassing agent
along with the regular clotting factors to make sure that any injury will heal.
After the body starts getting used to the clotting factors, the bypassing agent
is no longer needed.
If your body produces few inhibitors in reaction to clotting
you may be treated with clotting factor concentrate that is made in a lab (recombinant clotting factors). You might get large doses of the clotting factors, which can
overwhelm the inhibitors.
This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the
how we develop our content .